Marjolin\u27s Tumor Complicating Chronic Periprosthetic Infection of a Total Knee Arthroplasty by Horan, Timothy et al.
Philadelphia College of Osteopathic Medicine 
DigitalCommons@PCOM 
Orthopedic Surgery Resident Research Graduate Medical Education Research 
2019 
Marjolin's Tumor Complicating Chronic Periprosthetic Infection of 
a Total Knee Arthroplasty 
Timothy Horan 
Philadelphia College of Osteopathic Medicine 
Matthew T. Wallace 
Albert J. Aboulafia 
Janet D. Conway 
Follow this and additional works at: https://digitalcommons.pcom.edu/orthopedic_surgery_residents 
 Part of the Orthopedics Commons 
Recommended Citation 
Horan, Timothy; Wallace, Matthew T.; Aboulafia, Albert J.; and Conway, Janet D., "Marjolin's Tumor 
Complicating Chronic Periprosthetic Infection of a Total Knee Arthroplasty" (2019). Orthopedic Surgery 
Resident Research. 28. 
https://digitalcommons.pcom.edu/orthopedic_surgery_residents/28 
This Article is brought to you for free and open access by the Graduate Medical Education Research at 
DigitalCommons@PCOM. It has been accepted for inclusion in Orthopedic Surgery Resident Research by an 
authorized administrator of DigitalCommons@PCOM. For more information, please contact library@pcom.edu. 
J. Bone Joint Infect. 2019, Vol. 4 
 
 
http://www.jbji.net 
115 
Journal of Bone and Joint Infection 
2019; 4(3): 115-119. doi: 10.7150/jbji.34679 
Case Report 
Marjolin’s Tumor Complicating Chronic Periprosthetic 
Infection of a Total Knee Arthroplasty 
Timothy Horan1, Matthew T. Wallace2, Albert J. Aboulafia2, Janet D. Conway3 
1. Philadelphia College of Osteopathic Medicine Orthopaedic Surgery, Philadelphia, PA 
2. MedStar Georgetown Cancer Institute, National Center for Bone and Soft Tissue Tumors, MedStar Franklin Square Medical Center 
3. Rubin Institute for Advanced Orthopaedics, Baltimore, MD 
 Corresponding author: Mathew T. Wallace, 9103 Franklin Square Drive, Suite 2300, Baltimore, MD 21237. 443-777-2663; Matthew.T.Wallace@medstar.net 
© The authors. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/ 
by/4.0/). See http://ivyspring.com/terms for full terms and conditions. 
Received: 2019.03.06; Accepted: 2019.04.09; Published: 2019.04.20 
Abstract 
Marjolin’s tumor is a term used to describe a malignancy developing in the setting of a chronic 
wound, infection, or other tissue subject to chronic inflammatory changes. These malignancies 
usually present after many years of chronicity, and can range from lower grade basal cell carcinomas 
to high-grade sarcomas. We present the case of a squamous cell carcinoma that developed within a 
chronic periprosthetic infection of a total knee arthroplasty of 7 years duration. The intra-articular 
location, association with an orthopaedic implant, and brief latency period are all unique features of 
this case. 
  
Presentation
A 57 year-old female with a past medical history 
of rheumatoid arthritis on long-term hydroxychloro-
quine and leflunomide, as well as pulmonary embol-
ism and hypothyroidism, underwent left total knee 
arthroplasty (TKA) on 9/16/2009. She developed an 
acute hematogenously-seeded periprosthetic joint 
infection (PJI) of unspecified organism and under-
went debridement and exchange of polyethylene on 
6/7/2011, followed by 6 weeks of parenteral antibio-
tics. She was asymptomatic after this procedure until 
6/4/2012, at which time she developed a small cyst 
over the knee which was excised on 12/3/2012. This 
was complicated by wound healing difficulties, 
necessitating a split-thickness skin grafting 
procedure, which was then followed shortly by a 
second PJI. She underwent a 2-stage revision with 
explantation of components and antibiotic spacer 
insertion on 3/8/2013, followed by spacer removal 
and implantation of components on 6/4/2013. After 
persistence of PJI was suspected, she was referred to a 
musculoskeletal infection specialist for consultation 
(Figure 1). 
 
Figure 1. 7/30/2013. AP (A) and Lateral (B) radiographs at the time of initial 
consultation demonstrating a stemmed TKA with substantial effusion and 
patella alta. 
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The patient underwent explantation of her TKA 
and insertion of a PMMA antibiotic spacer impregna-
ted with vancomycin and tobramycin on 9/28/2013 
(Figure 2). Intraoperative cultures were positive for 
Pseudomonas aeruginosa, and she was prescribed a 
course of IV aztreonam and PO ciprofloxacin for 6 
weeks. Her postoperative course was complicated by 
a proximal tibial fracture, which was managed 
uneventfully in a long leg cast. A left knee aspiration 
and serologies performed on 12/10/2013 found no 
evidence of persistent infection. 
Revision TKA with stemmed implants was 
performed on 2/6/2014 with 5 intraoperative frozen 
section pathology specimens demonstrating no 
evidence of infection or acute inflammation. Her 
postoperative course was complicated this time by a 
left lower extremity DVT despite therapeutic couma-
din. After uneventful healing of her surgical wound, 
chronic venous stasis changes were observed in the 
lower extremity, managed with compression stock-
ings. At a 6 month postoperative visit on 8/5/2014 the 
patient reported “popping” of her knee and 
radiographs demonstrated loosening around the tibial 
component (Figure 3). An aspiration obtained at this 
visit demonstrated 41,310 WBC’s, 97% PMN’s, 
negative crystals and growth of coagulase negative 
Staphylococcus in broth only. A repeat aspiration on 
8/26/14 demonstrated 36,600 WBC’s, 97% PMN’s, no 
crystals and growth of coagulase negative 
Staphylococcus. Due to persistence of her infection now 
after two 2-stage revisions, it was recommended at 
this time that the patient undergo component 
explantation with a knee arthrodesis and an extended 
course of IV clindamycin and ciprofloxacin (Figure 4). 
This was performed on 12/15/2014. Surgical site 
pathology confirmed inflammatory debris. 
The patient tolerated this reconstruction well 
over the course of 15 months, at which point she 
presented on 3/2/2016 with persistent extremity 
edema that had failed aggressive conservative 
management. An aspiration of the knee was negative 
at this time. Over the ensuing months the patient 
developed a 5cm x 3cm anterior tibial wound without 
drainage or fistula formation. Local wound care was 
performed without improvement in the area of 
ulceration. A technetium-99m bone scan obtained on 
11/11/2016 demonstrated findings consistent with 
persistent osteomyelitis of the left anterior tibia. It was 
recommended that the patient undergo exchange of 
her arthrodesis nail and antibiotic spacer, followed by 
split-thickness skin grafting of her tibial wound, 
which she delayed until 5/18/2017 in favor of the 
patient’s preference for observation. Intraoperative 
cultures were positive for E. coli, coagulase negative 
Staphylococcus, beta-lactamase positive Bacteroides, and 
Enterococcus group D. The patient was initiated on IV 
aztreonam, PO doxycycline and PO metronidazole. 
She continued to develop multiple anterior venous 
stasis ulcerations of the left lower leg, one of which 
required an additional split-thickness skin grafting on 
11/16/2017 after failing conservative management. 
The patient presented on 1/8/2018 with 
increasing erythema, warmth, and new skin 
ulcerations over the anterior left tibia. Cultures of the 
ulcerations demonstrated Corynebacterium. Her 
inflammatory markers at this time were elevated; 
erythrocyte sedimentation rate (ESR) was 101 and 
c-reactive protein (CRP) was 87.2. Plain radiographs 
demonstrated progressive lytic changes of the tibia 
suggestive of abscess formation and osteomyelitis 
(Figure 5). A frank discussion was held regarding the 
surgical options for what was becoming an increasing 
compromised extremity. The patient was not 
receptive to a discussion of extremity ablation at this 
time, and after another period of observation, she 
agreed to undergo an additional exchange of her 
arthrodesis nail and antibiotic spacer. 
 
 
Figure 2. 9/30/2013. Postoperative AP (A) and Lateral (B) radiographs 
demonstrating appropriate alignment of the knee after explantation of 
components and PMMA antibiotic spacer insertion. 
 
 
Figure 3. 8/5/2014. AP (A) and Lateral (B) radiographs demonstrating 
substantial effusion of the knee joint, and lucency and periprosthetic loosening 
around the stemmed tibial implant. 
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Figure 4. 1/20/2015. AP (A) and Lateral (B) radiographs demonstrating a 
locked lower extremity arthrodesis nail through a static antibiotic cement 
block. 
 
 
Figure 5. 1/8/2018. AP (A) and lateral (B) radiographs demonstrating 
progressive lysis of the proximal tibia below the PMMA antibiotic cement 
spacer. 
 
 
Figure 6. Intraoperative appearance of wound demonstrating diffuse nodular 
involvement of the joint. 
On 7/5/2018 the patient returned to the 
operating room for a planned exchange of her 
arthrodesis rod, irrigation and debridement, and 
reinsertion of antibiotic cement spacer. Intraoperative 
cultures grew 3 different strains of E. coli, 
Beta-lactamase positive bacteroides, and enterococcus 
faecalis. Upon exposure, the tissue bed around the 
proximal tibia and distal femur was observed to have 
an unusual, pebble-like appearance (Figure 6). 
Intraoperative frozen section pathology consultation 
was obtained, returning a diagnosis of squamous cell 
carcinoma (Figure 7). The wound was closed and an 
orthopaedic oncology consultation was obtained. 
A staging CT of the chest abdomen and pelvis 
demonstrated an enlarged left inguinal lymph node 
without other signs of pulmonary or locoregional 
metastasis. Due to the extensive involvement and 
contamination of the joint with carcinoma, as well as 
the overall compromised nature of the extremity, 
ablation of the extremity was recommended with 
above knee amputation, combined with sentinel 
lymph node biopsy, which was performed on 
7/9/2018. The sentinel lymph node, measuring 6.3 by 
3.5 by 2.3 cm was negative for carcinoma, and 
consisted of an enlarged, reactive lymph node from 
chronic infection. Margins from the skin, soft tissue, 
and femoral canal were negative for malignancy. The 
patient was discharged with 2 weeks of oral 
doxycycline. She proceeded to heal her stump wound 
uneventfully. A restaging PET-CT performed 6 
months postoperatively demonstrated persistent 
reactive inflammatory lymphadenopathy in the left 
inguinal region, with no evidence of metastatic 
disease.  
Discussion 
The first observation of Marjolin’s ulcer (MU) is 
credited to Aurelius Cornelius Celsus in the first 
century, who described malignant changes in a burn 
scar.11 The term “Marjolin Ulcer” was coined by 
Robert Smith in 1850, who described the pathologic 
transformation of chronic wounds into malignancy. 
Malignancies observed include squamous cell 
carcinoma (SCC), basal cell carcinoma (BCC), 
melanoma and sarcoma.7 Marjolin’s Ulcer is a rare 
complication which has been observed in scar tissue, 
chronic ulcers, osteomyelitis, fistulas and any wound 
aggravated by persistent inflammation.11,12,17,19 The 
pathophysiology of chronic wounds undergoing 
malignant transformation has been debated over the 
past century and no specific factor has been 
identified.15 Prevailing theories suggest repetitive 
tissue damage leading to cellular proliferation, prone 
to spontaneous mutations. Necrotic tissue toxins may 
exacerbate mutations leading to inhibited apoptosis. 
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This is likely from a multifactorial etiology including 
environmental, immunological and genetic factors 
summarized in Table 1.11,13,14,15,16  
 
Table 1.  
Pathogenesis Of Marjolin’s Ulcer 
Chronic irritation theory 13 Repeated re-epithelialization induced 
carcinogenesis. 
Traumatic epithelial 
grafting theory 15 
Skin grafts into the dermis prompt an 
immunological response impairing physiologic 
healing. 
Cocarcinogen theory 17 Chemical toxins/physical injury stimulate latent 
malignant cell proliferation 
Initiation and promotion 
theory 15 
Two-stage process. Initiation phase where 
healthy cells turn into latent malignant cells. 
Promotion phase where malignant cells 
proliferate due to cocarcinogens, infection, etc.  
 Immunological theory 16 Sequestration of wound leads to avascularity and 
impaired immune surveillance leading to 
unregulated cell growth.  
 
Epidemiology 
Marjolin’s ulcer has been classically associated 
with burns, reported to occur as frequently in 2% of 
chronic burn scars.14 The most common malignancy 
observed as Marjolin tumors is squamous cell 
carcinoma (71%), followed by basal cell carcinoma 
(12%), melanoma (6%), sarcoma (5%), and other 
neoplasms (4%).2 The hallmark of Marjolin’s tumor is 
the chronicity of the primary disease. The average 
latency period is 32 years, but acute cases have been 
reported with malignant transformation occurring 
within 12 months.1,2 Marjolin’s ulcers most frequently 
affect the extremities, with a predilection for the lower 
extremities (53.3%), followed by the upper extremities 
(18.7%), torso (12.4%), and head and neck (5.8%).2 
Metastatic disease is observed in 32% of patients with 
squamous cell carcinoma.3  
Diagnosis 
Any chronic wound that undergoes a change in 
appearance or drainage should alert providers to the 
possibility of malignant transformation. A compre-
hensive history detailing the chronicity of the wound 
as well as attempted treatments should be document-
ed. Suspect lesions should undergo biopsy performed 
by or at the direction of the treating surgeon.10 Tissue 
sampling, either by percutaneous needle or incisional 
biopsy, should be planned with the definitive 
resection in mind.12 After histologic confirmation of 
malignancy, staging by way of local MRI and body CT 
or PET scan are recommended to identify lymph node 
and distant metastases.10 Staging provides a 
reproducible way to communicate disease burden 
and provides prognostic information.10  
Treatment 
Once the diagnosis of Marjolin’s ulcer is con-
firmed, collaboration with a multidisciplinary 
oncology team will ensure that general recommenda-
tions proposed by the AJCC will be followed.10 
Localized disease is generally managed with wide 
local excision with 2-4 cm negative margins.10,16, 17, 18 
High-risk tumors with extensive soft tissue or bone 
involvement, or locoregional lymph node spread may 
be best managed with amputation. Distant metastases 
may require resection, intensity-modulated radio-
therapy, or systemic chemotherapy as determined by 
the multidisciplinary oncology team9. 
Routinely-scheduled surveillance studies are 
monitored by the oncology team. 
Our case report presents several unique features 
to the Marjolin’s tumor. This mass developed as a 
consequence of long-standing periprosthetic joint 
infection in an immunosuppressed host, with a 
latency period of only 7 years, and an even shorter 
period of off-and-on wound drainage. Furthermore 
this malignancy developed in an intraosseous and 
intra-articular location, without superficial skin 
involvement. The case patient was fortunate, in that 
her locoregional lymphadenopathy was reactive in 
nature secondary to infection, and not consistent with 
metastatic spread. Ablation of the extremity was 
therefore potentially curative.  
 
 
Figure 7. Hematoxylin and eosin histopathology at Low (100x) (A) and High (200x) (B) power imaging demonstrating squamous cell carcinoma, with nests of 
epithelioid cells and distinguishing keratinous debris 
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Figure 8. Algorithm for diagnosis and management of Marjolin tumor. 
 
Conclusion 
Marjolin’s Ulcers are frequently aggressive 
tumors complicating chronically infected wounds and 
tissues of the extremities. To our knowledge, the 
incidence of malignant transformation in chronic 
periprosthetic joint infection is unknown. This 
unusual complication was identified intraoperatively 
by the recognition of a tissue bed with an atypical 
appearance, which highlights the importance of 
maintaining a high index of suspicion when manag-
ing chronic musculoskeletal infection. Consistent with 
the adage “culture what you biopsy and biopsy what 
you culture,” this case confirms that it is prudent to 
send material for histopathologic examination when 
performing debridement procedures, particularly 
when the appearance of the wound bed or drainage 
have changed. 
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